₹0.26
(Market cap
₹15 Cr
Recently Viewed
Clear AllMarket cap
₹15 Cr
Revenue (TTM)
₹49 Cr
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-2 Cr
ROE
2.6 %
ROCE
6 %
Industry P/E
30.6
EV/EBITDA
9.9
Debt to Equity
1.1
Book Value
₹13.1
EPS
₹0.3
Face value
10
Shares outstanding
6,510,015
CFO
₹-11.02 Cr
EBITDA
₹16.83 Cr
Net Profit
₹5.41 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zenlabs Ethica
| 15.5 | 25.8 | 21.1 | -27.0 | -23.4 | 0.4 | -- |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zenlabs Ethica
| -50.3 | -4.1 | -17.5 | 51.0 | 1.2 | -12.5 | -39.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zenlabs Ethica
|
23.0 | 15.0 | 49.3 | -1.9 | 2.2 | 2.2 | -- | 1.8 |
| 2,804.2 | 35,045.7 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.5 | 7.6 | |
| 8,369.0 | 20,952.5 | 2,177.5 | 200.9 | 11.3 | 26.5 | 104.3 | 25.2 | |
| 1,727.6 | 13,117.3 | 2,089.5 | 622.0 | 31.3 | 20.4 | 21.4 | 3.9 | |
| 1,316.2 | 18,223.9 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.2 | 5.0 | |
| 2,061.2 | 33,122.5 | 4,193.0 | 753.8 | 22.7 | 20.8 | 43.9 | 8.3 | |
| 4,763.0 | 21,794.9 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.5 | 5.5 | |
| 5,135.0 | 8,509.3 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29 | 12.2 | |
| 404.1 | 7,905.4 | 1,432.0 | 149.0 | 19.1 | 7.9 | 52.7 | 3.2 | |
| 1,053.5 | 9,708.1 | 4,725.6 | 528.7 | 14.9 | 20.7 | 19 | 3.3 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1993
Chairman
--
Managing Director
Sanjeev Kumar Singal
Headquarters
Chandigarh, Union Territory
Website
Looking for more details about Zenlabs Ethica Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Zenlabs Ethica Ltd is ₹22.99 (BSE) as of 29-Apr-2026 IST. Zenlabs Ethica Ltd has given a return of -23.41% in the last 3 years.
Since, TTM earnings of Zenlabs Ethica Ltd is negative, P/E ratio is not available.
The P/B ratio of Zenlabs Ethica Ltd is 1.75 times as on 29-Apr-2026, a 62 discount to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
75.48
|
1.95
|
|
2024
|
64.14
|
2.67
|
|
2023
|
91.88
|
4.63
|
|
2022
|
23.72
|
1.99
|
|
2021
|
17.94
|
1.61
|
The 52-week high and low of Zenlabs Ethica Ltd are Rs 39.20 and Rs 16.50 as of 29-Apr-2026.
Zenlabs Ethica Ltd has a market capitalisation of ₹ 15 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Zenlabs Ethica Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.